Open an account

Astrana Health

ASTH · NASDAQ

$38.58+$1.68 (+4.55%)TodayMarket closed ·
Prev close $36.90

About ASTH

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 3,000 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.

Employees
3,000
Headquarters
Alhambra, California
Listed
Apr 9, 1999
Sector
Health Care
Industry
Health Care Providers & Services
Website
astranahealth.com

ASTH key statistics

Market cap
1.91B
Price-earnings ratio
44.46
Dividend yield
0.10%
Average volume
357.29K
Volume
252.86K
Open price
$37.12
High today
$38.75
Low today
$37.12
52 Week high
$51.60
52 Week low
$18.08

Astrana Health (ASTH) at a glance

As of Oct 20, 2026, Astrana Health (ASTH) shares are priced at $38.58, giving the company a market cap of 1.91B, a price-to-earnings ratio of 44.46 and a dividend yield of 0.10%.

Today the stock has traded between $37.12 and $38.75. The current price is 3.9% above the day's low and 0.4% below its high.

Volume so far is 252.86K shares, below the average of 357.29K shares a day.

Over the past year Astrana Health has ranged from $18.08 to $51.60, and now sits 61% of the way up that range.

Astrana Health met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.40 per share against an estimate of $0.3427.

The average analyst price target is $51.82, 34.3% above the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 10 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 12 analystsAvg $51.82
Low
$41.41
Now
$38.58
High
$68.25

ASTH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 9.8% on average.

  1. Q3 FY24: reported $0.33 per share against an estimate of $0.3244
  2. Q4 FY24: reported -$0.15 per share against an estimate of $0.1199
  3. Q1 FY25: reported $0.14 per share against an estimate of $0.2517
  4. Q2 FY25: reported $0.19 per share against an estimate of $0.3704
  5. Q3 FY25: reported $0.01 per share against an estimate of $0.4501
  6. Q4 FY25: reported $0.12 per share against an estimate of $0.1081
  7. Q1 FY26: reported $0.29 per share against an estimate of $0.3049
  8. Q2 FY26: reported $0.40 per share against an estimate of $0.3427

ASTH news

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseBusiness Wire

    Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call

  • Press releaseBusiness Wire

    ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseGlobe Newswire

    Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Second Quarter 2026 Results

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

Similar companies

Companies in the same industry as Astrana Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.